Sugi Predict

Sugi Predict / Compounds / SCHEMBL244713

SCHEMBL244713

SCHEMBL244713

CCOC(C)OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.41
▸ CA9 Q16790 3/20 0.41
▸ CA12 O43570 2/20 0.41
▸ GAA P10253 3/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ GBA1 P04062 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ CA1 P00915 3/20 0.38
▸ CA7 P43166 2/20 0.38
▸ CA3 P07451 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA5B Q9Y2D0 1/20 0.38
▸ VDR P11473 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796822 0.92 CA2 (0.39) CA2CA9CA12GAAALDH1A1
SCHEMBL17662515 0.86 CA2 (0.37) CA2CA9CA12GAAALDH1A1
SCHEMBL890642 0.85 GAA (0.50) CA2CA9CA12GAAALDH1A1
SCHEMBL18301951 0.84 CA12 (0.41) CA2CA9CA12GAAALDH1A1
SCHEMBL17350537 0.82 AGER (0.39) CA2CA9CA12GAAALDH1A1
SCHEMBL361529 0.82 ALDH1A1 (0.43) CA2CA9CA12GAAALDH1A1
SCHEMBL21803209 0.82 GBA1 (0.40) CA2CA9CA12GAAALDH1A1
SCHEMBL9767627 0.82 GAA (0.46) CA2CA9CA12GAAALDH1A1
SCHEMBL8378760 0.81 ALDH1A1 (0.40) CA2CA9CA12GAAALDH1A1
SCHEMBL10784623 0.81 CA12 (0.41) CA2CA9CA12GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117800865-A Synthesis method of N, N '-dimethyl-N, N' -dioctyl hexyl oxyethyl malonamide 中核四0四有限公司 2024-04-02 — — CN claimed
JP-57063357-A — — None — — JP disclosed
CN-117800865-A Synthesis method of N, N '-dimethyl-N, N' -dioctyl hexyl oxyethyl malonamide 中核四0四有限公司 2024-04-02 — — CN disclosed
CN-117800865-A Synthesis method of N, N '-dimethyl-N, N' -dioctyl hexyl oxyethyl malonamide 中核四0四有限公司 2024-04-02 — — CN disclosed
WO-2020065475-A1 TITLE: PROCESS FOR THE PREPARATION OF BILASTINE GLENMARK LIFE SCIENCES LIMITED; GLENMARK PHARMACEUTICALS LIMITED (IN) 2020-04-02 — — WO disclosed
CN-107108575-B Novel benzimidazole derivatives as antihistamines 费斯制药股份有限公司 2019-07-26 — — CN disclosed
US-20190047968-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES FMC CORP (US) 2019-02-14 — — US disclosed
EP-3240783-B1 NEW BENZIMIDAZOLE DERIVATIVES AS ANTIHISTAMINE AGENTS FAES FARMA SA (ES) 2018-11-21 — — EP disclosed
US-10106522-B2 Benzimidazole derivatives as antihistamine agents FAES FARMA, S.A. (ES) 2018-10-23 — — US disclosed
US-10081608-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides FMC CORPORATION (US) 2018-09-25 — — US disclosed
US-6232320-B1 THIENO(2,3-C)PYRIDINE AND 5H-THIENO(2,3-C)PYRAN DERIATIVES ABBOTT LABORATORIES 2001-05-15 — — US disclosed
EP-1090009-A2 CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS ABBOTT LABORATORIES (US) 2001-04-11 — — EP disclosed
WO-2000075145-A1 CELL ADHESION-INHIBITING ANTIINFLAMMATORY COMPOUNDS ABBOTT LABORATORIES (US) 2000-12-14 — — WO disclosed
WO-1999062908-A2 CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS ABBOTT LABORATORIES (US) 1999-12-09 — — WO disclosed
US-5216170-A Promoters of livestock; treatment of obesity BAYER AKTIENGESELLSCHAFT (DE) 1993-06-01 — — US disclosed
US-5028617-A Heteroarylethanol-pyridylalkylamines for controlling animal growth BAYER AKTIENGESELLSCHAFT (DE) 1991-07-02 — — US disclosed
JP-S5763357-A RESIN COMPOSITION SUMITOMO CHEM CO LTD 1982-04-16 — — JP disclosed
US-4156682-A Fluoran compounds and recording sheet containing them SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-05-29 — — US disclosed
US-4024157-A Fluoran compounds and recording sheet containing them SUMITOMO CHEMICAL COMPANY LIMITED (JA) 1977-05-17 — — US disclosed
US-3970671-A XANTHENE, PRESSURE SENSITIVE KANZAKI PAPER MANUFACTURING CO., LTD. (JA) 1976-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10081608-B2 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides DDT, AADAC, DAZAP1 CA2 1029/4885CA9 2627/4885CA12 2440/4885
US-10106522-B2 Benzimidazole derivatives as antihistamine agents HRH2, HRH1, HRH4 CA2 465/4885CA9 1764/4885CA12 2506/4885
US-20190047968-A1 6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES DDT, AADAC, DAZAP1 CA2 1029/4885CA9 2627/4885CA12 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.